The cognitive impairments suffered by AD patients are associated with cholinergic neurotransmission, which seems to be closely related to the pathological formation of ß-amyloid5,6; therefore, cholinergic drugs like acetylcholinesterase (AChE) inhibitors7–11 are currently the most commonly prescribed. The gene discussed is ACHE; the disease is Alzheimer disease.